Literature DB >> 25505283

Direct and indirect effects of immune and central nervous system-resident cells on human oligodendrocyte progenitor cell differentiation.

Craig S Moore1, Qiao-Ling Cui1, Nebras M Warsi1, Bryce A Durafourt1, Nika Zorko1, David R Owen1, Jack P Antel1, Amit Bar-Or2.   

Abstract

In multiple sclerosis, successful remyelination within the injured CNS is largely dependent on the survival and differentiation of oligodendrocyte progenitor cells. During inflammatory injury, oligodendrocytes and oligodendrocyte progenitor cells within lesion sites are exposed to secreted products derived from both infiltrating immune cell subsets and CNS-resident cells. Such products may be considered either proinflammatory or anti-inflammatory and have the potential to contribute to both injury and repair processes. Within the CNS, astrocytes also contribute significantly to oligodendrocyte biology during development and following inflammatory injury. The overall objective of the current study was to determine how functionally distinct proinflammatory and anti-inflammatory human immune cell subsets, implicated in multiple sclerosis, can directly and/or indirectly (via astrocytes) impact human oligodendrocyte progenitor cell survival and differentiation. Proinflammatory T cell (Th1/Th17) and M1-polarized myeloid cell supernatants had a direct cytotoxic effect on human A2B5(+) neural progenitors, resulting in decreased O4(+) and GalC(+) oligodendrocyte lineage cells. Astrocyte-conditioned media collected from astrocytes pre-exposed to the same proinflammatory supernatants also resulted in decreased oligodendrocyte progenitor cell differentiation without an apparent increase in cell death and was mediated through astrocyte-derived CXCL10, yet this decrease in differentiation was not observed in the more differentiated oligodendrocytes. Th2 and M2 macrophage or microglia supernatants had neither a direct nor an indirect impact on oligodendrocyte progenitor cell differentiation. We conclude that proinflammatory immune cell responses can directly and indirectly (through astrocytes) impact the fate of immature oligodendrocyte-lineage cells, with oligodendrocyte progenitor cells more vulnerable to injury compared with mature oligodendrocytes.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25505283     DOI: 10.4049/jimmunol.1401156

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

Review 1.  Control of autoimmune CNS inflammation by astrocytes.

Authors:  Veit Rothhammer; Francisco J Quintana
Journal:  Semin Immunopathol       Date:  2015-07-30       Impact factor: 9.623

Review 2.  Roles of microglia in brain development, tissue maintenance and repair.

Authors:  Mackenzie A Michell-Robinson; Hanane Touil; Luke M Healy; David R Owen; Bryce A Durafourt; Amit Bar-Or; Jack P Antel; Craig S Moore
Journal:  Brain       Date:  2015-03-29       Impact factor: 13.501

Review 3.  Immune cell regulation of glia during CNS injury and disease.

Authors:  Andrew D Greenhalgh; Sam David; F Chris Bennett
Journal:  Nat Rev Neurosci       Date:  2020-02-10       Impact factor: 34.870

Review 4.  Remyelination therapies: a new direction and challenge in multiple sclerosis.

Authors:  Jason R Plemel; Wei-Qiao Liu; V Wee Yong
Journal:  Nat Rev Drug Discov       Date:  2017-07-07       Impact factor: 84.694

Review 5.  Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases.

Authors:  Zhaoqi Yan; Sara A Gibson; Jessica A Buckley; Hongwei Qin; Etty N Benveniste
Journal:  Clin Immunol       Date:  2016-10-03       Impact factor: 3.969

Review 6.  Regenerative Role of T Cells in Nerve Repair and Functional Recovery.

Authors:  Xiaoxuan Tang; Qiaoyuan Li; Tingting Huang; Han Zhang; Xiaoli Chen; Jue Ling; Yumin Yang
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

Review 7.  Regulation of human glia by multiple sclerosis disease modifying therapies.

Authors:  Luke M Healy; Mackenzie A Michell-Robinson; Jack P Antel
Journal:  Semin Immunopathol       Date:  2015-08-11       Impact factor: 9.623

Review 8.  Targeting human oligodendrocyte progenitors for myelin repair.

Authors:  Karen C Dietz; Jessie J Polanco; Suyog U Pol; Fraser J Sim
Journal:  Exp Neurol       Date:  2016-03-18       Impact factor: 5.330

Review 9.  Understanding the Role of Antiviral Cytokines and Chemokines on Neural Stem/Progenitor Cell Activity and Survival.

Authors:  Manisha N Chandwani; Patrick S Creisher; Lauren A O'Donnell
Journal:  Viral Immunol       Date:  2018-10-10       Impact factor: 2.257

Review 10.  Remyelination Therapy in Multiple Sclerosis.

Authors:  Danielle E Harlow; Justin M Honce; Augusto A Miravalle
Journal:  Front Neurol       Date:  2015-12-10       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.